ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) major shareholder Global Fund Lp Lind II sold 381,676 shares of ReWalk Robotics stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $3.36, for a total value of $1,282,431.36. Following the transaction, the insider now owns 1,049,430 shares in the company, valued at approximately $3,526,084.80. This represents a 26.67 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
ReWalk Robotics Stock Down 10.4 %
Shares of ReWalk Robotics stock opened at $1.98 on Thursday. ReWalk Robotics Ltd. has a twelve month low of $1.41 and a twelve month high of $8.89. The company has a 50-day simple moving average of $1.95 and a two-hundred day simple moving average of $2.90. The stock has a market capitalization of $17.44 million, a price-to-earnings ratio of -0.80 and a beta of 2.08.
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.08). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The company had revenue of $6.13 million during the quarter, compared to analyst estimates of $8.38 million. During the same period last year, the firm earned ($0.56) EPS. On average, sell-side analysts anticipate that ReWalk Robotics Ltd. will post -1.78 earnings per share for the current fiscal year.
Analyst Ratings Changes
Read Our Latest Research Report on ReWalk Robotics
Institutional Inflows and Outflows
An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP purchased a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned approximately 0.16% of ReWalk Robotics at the end of the most recent quarter. 26.76% of the stock is currently owned by institutional investors.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Further Reading
- Five stocks we like better than ReWalk Robotics
- Which Wall Street Analysts are the Most Accurate?
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 Growth
- Using the MarketBeat Dividend Yield Calculator
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.